All In Biotech

Drug Trial Radar · NCT03301506

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)

Last checked: Nov 20, 2026Latest source record: May 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

340

Planned (sponsor's estimate)

Start

Dec 12, 2017

Primary completion

Nov 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Gilead SciencesGilead Sciences (GILD)
Sponsor type
Industry
First posted
Oct 4, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Conditions

  • Primary Biliary Cirrhosis

Interventions

  • Seladelpar 5 mg CapsuleDrug

    Participants will be assigned to a treatment group if tolerability issues noted in the previous study.

  • Seladelpar 10 mg CapsuleDrug

    Participants will be assigned to a treatment group unless there are tolerability issues.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment emergent adverse events (TEAEs) (National Cancer Institute {NCI} Common Terminology Criteria for Adverse Events {CTCAE} Version 5.0), biochemistry and hematology resultsTime frame: Through study completion, up to 60 Months

Locations

109 sites in 25 countries. Site status is shown where the registry gives one.

  • Arkansas Diagnostic Center

    Little Rock, Arkansas

  • Stanford University School of Medicine

    Palo Alto, California

  • California Liver Research Institute

    Pasadena, California

  • University of California Davis Medical Center

    Sacramento, California

  • California Pacific Medical Center

    San Francisco, California

  • University of Colorado - Denver - PPDS

    Aurora, Colorado

  • Yale University School of Medicine

    New Haven, Connecticut

  • Covenant Research Fort Myers

    Fort Myers, Florida

  • Florida Digestive Health Specialist

    Lakewood Rch, Florida

  • University of Miami Miller School of Medicine

    Miami, Florida

  • Covenant Research, LLC

    Sarasota, Florida

  • Digestive Healthcare of Georgia PC

    Atlanta, Georgia

  • University of Chicago Hospitals

    Chicago, Illinois

  • East Jefferson General Hospital

    New Orleans, Louisiana

  • Mercy Medical Center (Baltimore)

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Beth Israel Deaconess Medical Center - 330 Brookline Ave

    Boston, Massachusetts

  • Henry Ford Health System

    Novi, Michigan

  • MNGI Digestive Health PA-Plymouth

    Minneapolis, Minnesota

  • Southern Therapy and Advanced Research LLC

    Jackson, Mississippi

  • Saint Louis University

    St Louis, Missouri

  • NYU Langone Medical Center

    New York, New York

  • Weill Cornell Medical College

    New York, New York

  • Icahn School of Medicine at Mount Sinai

    New York, New York

  • University of Rochester Medical Center - PPDS

    Rochester, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Northeast Clinical Research Center, LLC

    Bethlehem, Pennsylvania

  • Penn State Health Milton S. Hershey Medical Center

    Hershey, Pennsylvania

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • Galen Medical Group

    Chattanooga, Tennessee

  • Gastro One-8110 Walnut Run Rd

    Cordova, Tennessee

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • University of Texas Southwestern Medical Center

    Dallas, Texas

  • Liver Institute at Methodist Dallas

    Dallas, Texas

  • Baylor College of Medicine

    Houston, Texas

  • The Texas Liver Institute - 607 Camden St

    San Antonio, Texas

  • Pinnacle Clinical Research, PLLC

    San Antonio, Texas

  • Maryview Hospital Inc., d/b/a Bon Secours Liver Institute of Hampton Roads

    Newport News, Virginia

  • Bon Secours Richmond Community Hospital, Inc. d/b/a Bon Secours Liver Institute of Richmond

    Richmond, Virginia

  • Liver Institute Northwest, PLLC

    Seattle, Washington

Showing 40 of 109 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.